A recent study shows that statins, usually used for the treatment of hypercholesterolemia, increase the expression of neurotrophins in the brain; this result is due to the binding to a particular domain of PPARα, which is independent of the pathway typical of mevalonate. This evidence concerns the gene PPARA and Hypercholesterolemia.